Por Renan Filho · 2026-11-04**Lead**
The Golden State Warriors have reportedly ceased payment of Kristaps Porzingis' $20 million salary, according to multiple league sources familiar with the situation. The decision comes amid an ongoing mystery illness that has kept the 7-foot-3 forward away from basketball activities for an extended period. Neither the team nor Porzingis' representatives have issued official statements, but the move signals a dramatic escalation in what had been a quietly simmering contract dispute.
**Context**
Porzingis, 29, was acquired by the Warriors in a complex sign-and-trade arrangement during the 2023 offseason, a deal that sent several players and draft picks to the Washington Wizards. At the time, Golden State hoped his unique skill set — combining elite perimeter shooting with rim protection — would provide a final piece to extend their championship window alongside Stephen Curry and Draymond Green. However, Porzingis has played in only 17 games this season due to what the team has vaguely termed a "non-basketball-related medical issue." The nature of the illness has never been disclosed, fueling speculation ranging from chronic fatigue to a rare autoimmune disorder.
The $20 million figure represents Porzingis' base salary for the current season, part of a four-year, $120 million contract signed in 2019. Under the NBA's collective bargaining agreement, teams are generally required to pay players for games missed due to injury or illness, unless the condition is determined to be a pre-existing or non-basketball-related matter that voids the guarantee. The Warriors' alleged decision to withhold payment suggests they believe Porzingis' condition falls into that category, though independent medical opinions have not been made public.
Porzingis has a history of significant injuries, including a torn ACL in 2018 that cost him an entire season and persistent knee problems that limited his availability with the Dallas Mavericks and Wizards. However, the current episode is shrouded in greater secrecy than previous setbacks. Sources indicate that team doctors have been unable to reach a definitive diagnosis, leading to frustration within the organization.
**Analise**
If the reports are accurate, this could set a major precedent in the NBA regarding salary guarantees and player health transparency. The Warriors are already facing a luxury tax bill exceeding $100 million, and any savings from Porzingis' contract would provide immediate financial relief. With the team hovering around .500 and struggling to integrate young talent, the front office may view this as a way to free up cap space for a potential trade deadline move. However, the Players Association is likely to scrutinize any attempt to withhold pay, especially without a clear medical consensus.
The mystery illness saga also raises broader questions about the physical toll on modern basketball players. The league has seen a rise in unusual medical cases, from blood clots to myocarditis, and teams are increasingly conservative with player workload. Yet the lack of disclosure here creates an atmosphere of suspicion. Fans and analysts are left to wonder whether Porzingis is genuinely incapacitated or whether the relationship with the franchise has broken down to the point of no return.
For Porzingis, the financial hit could be devastating. Beyond the lost wages, his reputation as a reliable player — already damaged by past injuries — takes another blow. If the grievance goes to arbitration, he might recover some of the money, but the process could drag on for months. Meanwhile, the Warriors must manage the locker room impact. Teammates have been careful in their public comments, but internal sources describe a sense of uncertainty about Porzingis' future with the team.
**Fontes**
Multiple league sources; NBA collective bargaining agreement stipulations; historical injury reports from the Dallas Mavericks and Washington Wizards; team salary cap data from the NBA's official transparency records.